These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2887331

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide.
    Lowry PW, Franklin CL, Weaver AL, Szumlanski CL, Mays DC, Loftus EV, Tremaine WJ, Lipsky JJ, Weinshilboum RM, Sandborn WJ.
    Gut; 2001 Nov; 49(5):656-64. PubMed ID: 11600468
    [Abstract] [Full Text] [Related]

  • 3. Sulphasalazine desensitization in a paediatric patient with juvenile chronic arthritis.
    Kümmerle-Deschner J, Dannecker G.
    Acta Paediatr; 1995 Aug; 84(8):952-4. PubMed ID: 7488828
    [Abstract] [Full Text] [Related]

  • 4. Sulphasalazine desensitisation in patients with arthritis.
    McCarthy C, Coughlan R.
    Ir J Med Sci; 1994 May; 163(5):238-9. PubMed ID: 7913919
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Leucopenia, thrombocytopenia and lymphadenopathy associated with sulphasalazine.
    McKenna KE, Burrows D.
    Clin Exp Dermatol; 1994 Sep; 19(5):419-20. PubMed ID: 7955504
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.
    Bax DE, Amos RS.
    Ann Rheum Dis; 1986 Feb; 45(2):139-40. PubMed ID: 2868699
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Leucopenia in rheumatoid arthritis: relationship to gold or sulphasalazine therapy.
    Amos RS, Bax DE.
    Br J Rheumatol; 1988 Dec; 27(6):465-8. PubMed ID: 2904830
    [Abstract] [Full Text] [Related]

  • 15. Sulphasalazine and prednisone compared with sulphasalazine for treating active Crohn disease. A double-blind, randomized, multicenter trial.
    Rijk MC, van Hogezand RA, van Lier HJ, van Tongeren JH.
    Ann Intern Med; 1991 Mar 15; 114(6):445-50. PubMed ID: 1671631
    [Abstract] [Full Text] [Related]

  • 16. Sulphasalazine. An alternative drug for second-line treatment of juvenile chronic arthritis.
    Varbanova BB, Dyankov ED.
    Adv Exp Med Biol; 1999 Mar 15; 455():331-6. PubMed ID: 10599365
    [Abstract] [Full Text] [Related]

  • 17. Sulphasalazine induced hepatitis in juvenile rheumatoid arthritis.
    Caspi D, Fuchs D, Yaron M.
    Ann Rheum Dis; 1992 Feb 15; 51(2):275-6. PubMed ID: 1347987
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.